Ownership

Mark Mcdade - Director at Tourmaline Bio, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: TRML on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Mark Mcdade - trading volume in the past year for Tourmaline Bio, Inc.

	Shares	%	Avg Price	Total $
Buys	+100K	100%	$32.50	+$3.25M
Sells
Net	+100K	100%		+$3.25M

Holdings reported by Mark Mcdade for Tourmaline Bio, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	448K	$14.6M	$32.50	Jan 29, 2024	By Qiming U.S. Healthcare Fund III,L.P.
Common Stock	183K	$5.95M	$32.50	Jan 29, 2024	By Qiming U.S. Healthcare Fund I,L.P.
Common Stock	110K	$3.58M	$32.50	Jan 29, 2024	By Qiming U.S. Healthcare Fund II,L.P.
Common Stock	518	$16.8K	$32.50	Jan 29, 2024	Direct
Stock Option (Right to Buy)	10K			Jun 5, 2024	Direct	Common Stock

Transactions reported by Mark Mcdade for Tourmaline Bio, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.